Algert Global LLC Care Dx, Inc. Transaction History

Algert Global LLC

$4.25 Billion
Q4 2024

A detailed history of Algert Global LLC transactions in Care Dx, Inc. stock. As of the latest transaction made, Algert Global LLC holds 36,040 shares of CDNA stock, worth $647,278. This represents 0.02% of its overall portfolio holdings.

Number of Shares

36,040

Previous 28,580 26.1%

Holding current value

$647,278

Previous $892,000 13.45%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$20.4 - $32.2 $152,184 - $240,212	7,460 Added 26.1%	36,040 $772,000
Q3 2024 Nov 12, 2024	BUY	$14.41 - $33.99 $411,837 - $971,434	28,580 New	28,580 $892,000
Q3 2023 Nov 13, 2023	SELL	$7.0 - $11.26 $48,790 - $78,482	-6,970 Reduced 5.27%	125,210 $876,000
Q2 2023 Aug 14, 2023	BUY	$7.61 - $9.46 $777,894 - $967,001	102,220 Added 341.19%	132,180 $1.12 Million
Q1 2023 May 12, 2023	SELL	$8.83 - $17.61 $148,034 - $295,231	-16,765 Reduced 35.88%	29,960 $274,000
Q4 2022 Feb 13, 2023	BUY	$10.88 - $20.05 $8,595 - $15,839	790 Added 1.72%	46,725 $533,000
Q3 2022 Nov 15, 2022	BUY	$16.06 - $26.39 $440,011 - $723,033	27,398 Added 147.8%	45,935 $782,000
Q2 2022 Aug 15, 2022	SELL	$20.49 - $39.72 $345,707 - $670,155	-16,872 Reduced 47.65%	18,537 $398,000
Q1 2022 May 16, 2022	BUY	$28.19 - $46.6 $420,369 - $694,899	14,912 Added 72.75%	35,409 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$41.2 - $73.6 $241,020 - $430,559	5,850 Added 39.94%	20,497 $932,000
Q3 2021 Nov 15, 2021	BUY	$59.15 - $91.99 $866,370 - $1.35 Million	14,647 New	14,647 $928,000

Others Institutions Holding CDNA

# of Institutions

218

Shares Held

53.2M

Call Options Held

53.5K

Put Options Held

23.9K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $960M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.

Account

Algert Global LLC Care Dx, Inc. Transaction History